PND23 Economic Evaluation of Natalizumab Versus Fingolimod for the Treatment of Relapsing-Remitting Multiple Sclerosis in Sweden

Jun 1, 2012, 00:00
10.1016/j.jval.2012.03.782
https://www.valueinhealthjournal.com/article/S1098-3015(12)00847-9/fulltext
Title : PND23 Economic Evaluation of Natalizumab Versus Fingolimod for the Treatment of Relapsing-Remitting Multiple Sclerosis in Sweden
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)00847-9&doi=10.1016/j.jval.2012.03.782
First page : A145
Section Title : Neurological Disorders
Open access? : No
Section Order : 267
Categories :
Tags :
Regions :
ViH Article Tags :